Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-1

Therapy of highly active pediatric multiple sclerosis

Peter Huppke, Brenda Huppke, David Ellenberger [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2012-8

Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis

Jai S Perumal, Farng Foo, Perry Cook [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-1

Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies

Ricardo Alonso, Magdalena Casas, Luciana Lazaro [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2024-7

Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico

Sergio Sauri-Suarez, Sandra Quiñones, Manuel De la Maza-Flores [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Case report

First published 2018

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis

Katja Akgün, Imke Metz, Hagen H. Kitzler [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2018-11-27

Vestibular rehabilitation has positive effects on balance,fatigue and activities of daily living in highly disabled multiple sclerosis people: A preliminary randomized controlled trial

Marco Tramontano, Alex Martino Cinnera, Leonardo Manzari [...]

Restorative Neurology and Neuroscience

Open access

Review article

First published 2023-7

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs

Susana Otero-Romero, Christine Lebrun-Frénay, Saúl Reyes [...]

Multiple Sclerosis Journal

Open access

Brief report

First published 2019-7

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis

Monica Margoni, Francesca Rinaldi, Silvia Miante [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2024-2

Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis

Melany Venet, Anne Lepine, Adil Maarouf [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2025

Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study

Tjalf Ziemssen, Ann D. Bass, Bart Van Wijmeersch [...]

Therapeutic Advances in Neurological Disorders

Search results